Home
Products
Reagents for Polymerization
Polymerization Catalysts
Cross-Coupling Reaction Catalyst
4-((4'-CHLORO-3'-METHYLPHENOXY)METHYL)P&

4-((4'-CHLORO-3'-METHYLPHENOXY)METHYL)P&

Name: 4-((4'-CHLORO-3'-METHYLPHENOXY)METHYL)P&
Brand: BOC Sciences
Rating: 5 (1 reviews)

Inquiry

Molecular Formula:

C14H14BClO3

Molecular Weight:

276.526

CAS Number:

849052-25-1

Catalog Number:

849052-25-1

Product Information

Molecular Formula:

C14H14BClO3

Molecular Weight:

276.526

Description

4-((4'-CHLORO-3'-METHYLPHENOXY)METHYL)P& is an exquisitely efficacious pharmaceutical chemical employed in the management of select neoplastic diseases. It aims at precise neoplastic cells, impeding their proliferation and averting metastatic dissemination. Through selective receptor engagement on neoplastic cells, this substance successfully stifles tumorigenesis, showcasing a remarkable inhibition of neoplastic cellularity expansion.

Synonyms

4-((4'-CHLORO-3'-METHYLPHENOXY)METHYL)P&; 4-((4'-Chloro-3'-methylphenoxy)methyl)phenylboronic

IUPAC Name

[4-[(4-chloro-3-methylphenoxy)methyl]phenyl]boronic acid

Canonical SMILES

B(C1=CC=C(C=C1)COC2=CC(=C(C=C2)Cl)C)(O)O

InChI

InChI=1S/C14H14BClO3/c1-10-8-13(6-7-14(10)16)19-9-11-2-4-12(5-3-11)15(17)18/h2-8,17-18H,9H2,1H3

InChI Key

OUKUADBAEFEIGP-UHFFFAOYSA-N

Purity

98%

Safety Information

Hazards

H413

Computed Properties

Hydrogen Bond Donor Count

Hydrogen Bond Acceptor Count

Rotatable Bond Count

Exact Mass

276.0724522 g/mol

Monoisotopic Mass

276.0724522 g/mol

Topological Polar Surface Area

49.7Å²

Heavy Atom Count

Formal Charge

Complexity

269

Isotope Atom Count

Defined Atom Stereocenter Count

Undefined Atom Stereocenter Count

Defined Bond Stereocenter Count

Undefined Bond Stereocenter Count

Covalently-Bonded Unit Count

Compound Is Canonicalized

Yes

Patents

Publication Number	Title	Priority Date
AU-2016290152-A1	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication	2015-07-06
CA-2990575-A1	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication	2015-07-06
EP-3319958-A1	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication	2015-07-06
JP-2018520162-A	Pyridin-3-ylacetic acid derivatives as inhibitors of human immunodeficiency virus replication	2015-07-06
US-2018170903-A1	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication	2015-07-06
WO-2017006261-A1	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication	2015-07-06
US-2012149693-A1	Therapeutic compounds	2009-05-05
US-2015315127-A1	Therapeutic compounds	2009-05-05
US-9024071-B2	Therapeutic compounds	2009-05-05
PT-2017314-E	ACIDS AND BORON ESTERS AS HYDROLASE INHIBITORS OF FATTY ACID AMIDES	2007-07-20

Literatures

PMID	Publication Date	Title	Journal
5452	1976-05-25	The mechanism of superoxide anion generation by the interaction of phenylhydrazine with hemoglobin	The Journal of biological chemistry
5574	1976-05-01	Neurotrophic activity of brain extracts in forelimb regeneration of the urodele, Triturus	The Journal of experimental zoology
4927	1976-01-01	[Proceedings: Serum gamma-glutamyl tranapeptidase activity after the induction and inhibition of liver microsomal enzymes in nonconjugated hyperbilirubinemia]	Vutreshni bolesti
1117	1975-12-01	The inhibition of the motility of human spermatozoa by various pharmacologic agents	Biology of reproduction